Ductal carcinoma in situ in breast carcinogenesis

Paul J. Van Diest

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations


Evidence is mounting that ductal carcinoma in situ (DCIS) is a direct precursor of invasive breast cancer. Recent molecular biological and cytogenetic studies have revealed chromosomal gains and losses involved in breast carcinogenesis. This editorial discusses how the gains and losses on the different chromosomes fit into previously defined morphological routes of progression from normal cells through DCIS to invasive carcinoma, and the possible uses of these gains and losses in the classification of DCIS and the risk assessment of DCIS patients.

Original languageEnglish (US)
Pages (from-to)383-384
Number of pages2
JournalJournal of Pathology
Issue number4
StatePublished - Mar 17 1999


  • Breast
  • Classification
  • Comparative genomic hybridization
  • Cytogenetics
  • Ductal carcinoma in situ
  • Prognosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine


Dive into the research topics of 'Ductal carcinoma in situ in breast carcinogenesis'. Together they form a unique fingerprint.

Cite this